Amrutanjan Health Care Q2 Results
- BSE: 590006
- NSE: AMRUTANJAN
- ISIN: INE098F01031
- Sector: Biotechnology & Drugs
BSE
631.65
2.60 (0.41%)
2.60 (0.41%)Volume307.00
Updated: Fri 6 Feb, 2026 | 14:49:45
NSE
6344.35 (0.69%)
4.35 (0.69%)Volume6.17 K
Updated: Fri 6 Feb, 2026 | 15:25:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Amrutanjan Health Care Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 102.73 | 87.13 | 17.91% | 97.97 | 4.86% |
| Depreciation/ Amortization | 1.56 | 1.53 | 1.76% | 1.65 | -5.75% |
| Operating Income | 14.97 | 6.92 | 116.40% | 11.95 | 25.27% |
| Net Income | 13.96 | 8.31 | 67.99% | 11.80 | 18.36% |
| Other Operating Expenses Total | 13.82 | 12.83 | 7.75% | 12.48 | 10.73% |
| Net Income Before Taxes | 19.21 | 11.29 | 70.15% | 15.94 | 20.54% |
| Total Revenue | 117.70 | 94.05 | 25.15% | 109.92 | 7.08% |
| Selling/ General/ Admin Expenses Total | 29.70 | 23.38 | 27.02% | 29.43 | 0.93% |
| Diluted Normalized EPS | 4.83 | 2.87 | 68.29% | 4.08 | 18.38% |